Rare Disease Day 2018
Today is Rare Disease Day 2018. Celebrated on the last day of February every year, Rare Disease Day aims to raise awareness about rare diseases and their impact on patients’ lives around the world. A [...]
EMA survey on Brexit preparedness
Late last month, the European Medicines Agency (EMA) released a survey to help assess pharmaceutical companies’ preparedness for Brexit. The purpose of this assessment is to identify and address any issues that could potentially disrupt [...]
States introducing bills to allow drug importation from Canada
Prescription drug prices in the US are steadily rising and, with little progress being made to solve the problem at the national level, state legislators are now taking matters into their own hands. Already in [...]
The CREATES Act not passed as part of US budget plan
President Donald Trump has recently released his budget plan, and many within the healthcare sector are disappointed to see that The Creating and Restoring Equal Access to Equivalent Samples Act, or CREATES Act for short, [...]
Repurposing generic and off-patent drugs
As healthcare costs around the world continue to rise, regulators are working on developing solutions that will help provide reliable and more affordable treatment options for patients. One such solution is drug repurposing, which involves [...]
Repurposing generic and off-patent drugs
As healthcare costs around the world continue to rise, regulators are working on developing solutions that will help provide reliable and more affordable treatment options for patients. One such solution is drug repurposing, which involves [...]
Letter sent to Congress opposing Right to Try
The Right to Try movement in the US has been gathering momentum in the past year. Currently, 38 US states have enacted Right to Try legislation, and national-level legislation is now being considered by Congress, [...]
FDA to implement further 21st Century Cures Act provisions in 2018
The 21st Century Cures Act was designed to help accelerate drug development and approval processes and bring novel medical advances to patients quicker and more efficiently. The legislation, which was passed into law at the [...]